InvestorsHub Logo
icon url

Foose

05/25/18 3:32 PM

#51981 RE: tagmonster #51980

Except for the part where Colorcon still needs to revise their DMF and FDA will need to do a more in depth review - JHL2 posts a few days ago - before a pharma company can actually use it.

The devil is in the details.